Binding Preferences for GPIHBP1, a Glycosylphosphatidylinositol-anchored Protein of Capillary Endothelial Cells

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2010 Oct 23

PMID 20966398

Citations 34

Authors

Peter Gin

Anne P Beigneux

Constance Voss

Brandon S J Davies

Jennifer A Beckstead

Robert O Ryan

Andre Bensadoun

Loren G Fong

Stephen G Young

Affiliations

Soon will be listed here.

Abstract

Objective: To define the ability of GPIHBP1 to bind other lipase family members and other apolipoproteins (apos) and lipoproteins.

Methods And Results: GPIHBP1, a GPI-anchored lymphocyte antigen (Ly)6 protein of capillary endothelial cells, binds lipoprotein lipase (LPL) avidly, but its ability to bind related lipase family members has never been evaluated. As judged by cell-based and cell-free binding assays, LPL binds to GPIHBP1, but other members of the lipase family do not. We also examined the binding of apoAV-phospholipid disks to GPIHBP1. ApoAV binds avidly to GPIHBP1-transfected cells; this binding requires GPIHBP1's amino-terminal acidic domain and is independent of its cysteine-rich Ly6 domain (the latter domain is essential for LPL binding). GPIHBP1-transfected cells did not bind high-density lipoprotein. Chylomicrons bind avidly to GPIHBP1-transfected Chinese hamster ovary cells, but this binding is dependent on GPIHBP1's ability to bind LPL within the cell culture medium.

Conclusions: GPIHBP1 binds LPL but does not bind other lipase family members. GPIHBP1 binds apoAV but does not bind apoAI or high-density lipoprotein. The ability of GPIHBP1-transfected Chinese hamster ovary cells to bind chylomicrons is mediated by LPL; chylomicron binding does not occur unless GPIHBP1 first captures LPL from the cell culture medium.

Citing Articles

Lipoprotein Lipase: Structure, Function, and Genetic Variation.

Perera S, Wang J, McIntyre A, Hegele R Genes (Basel). 2025; 16(1).

PMID: 39858602 PMC: 11764694. DOI: 10.3390/genes16010055.

The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processing.

Song W, Beigneux A, Weston T, Chen K, Yang Y, Nguyen L Proc Natl Acad Sci U S A. 2023; 120(44):e2313825120.

PMID: 37871217 PMC: 10623010. DOI: 10.1073/pnas.2313825120.

Role of glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes.

Kurooka N, Eguchi J, Wada J J Diabetes Investig. 2023; 14(10):1148-1156.

PMID: 37448184 PMC: 10512915. DOI: 10.1111/jdi.14056.

A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism.

Young S, Song W, Yang Y, Birrane G, Jiang H, Beigneux A Proc Natl Acad Sci U S A. 2022; 119(36):e2211136119.

PMID: 36037340 PMC: 9457329. DOI: 10.1073/pnas.2211136119.

Addressing dyslipidemic risk beyond LDL-cholesterol.

Tall A, Thomas D, Gonzalez-Cabodevilla A, Goldberg I J Clin Invest. 2022; 132(1.

PMID: 34981790 PMC: 8718149. DOI: 10.1172/JCI148559.

References

Beigneux A, Gin P, Davies B, Weinstein M, Bensadoun A, Fong L . Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase. J Biol Chem. 2009; 284(44):30240-7. PMC: 2781579. DOI: 10.1074/jbc.M109.046391. View

Sendak R, Melford K, Kao A, Bensadoun A . Identification of the epitope of a monoclonal antibody that inhibits heparin binding of lipoprotein lipase: new evidence for a carboxyl-terminal heparin-binding domain. J Lipid Res. 1998; 39(3):633-46. View

Ioka R, Kang M, Kamiyama S, Kim D, Magoori K, Kamataki A . Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1. J Biol Chem. 2002; 278(9):7344-9. DOI: 10.1074/jbc.M211932200. View

Wong H, Davis R, Thuren T, Goers J, Nikazy J, Waite M . Lipoprotein lipase domain function. J Biol Chem. 1994; 269(14):10319-23. View

Young S, Davies B, Fong L, Gin P, Weinstein M, Bensadoun A . GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons. Curr Opin Lipidol. 2007; 18(4):389-96. PMC: 2888298. DOI: 10.1097/MOL.0b013e3281527914. View

Gin P, Yin L, Davies B, Weinstein M, Ryan R, Bensadoun A . The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons. J Biol Chem. 2008; 283(43):29554-62. PMC: 2662032. DOI: 10.1074/jbc.M802579200. View

Beigneux A, Davies B, Gin P, Weinstein M, Farber E, Qiao X . Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 2007; 5(4):279-91. PMC: 1913910. DOI: 10.1016/j.cmet.2007.02.002. View

Lookene A, Beckstead J, Nilsson S, Olivecrona G, Ryan R . Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism. J Biol Chem. 2005; 280(27):25383-7. DOI: 10.1074/jbc.M501589200. View

Weinstein M, Yin L, Tu Y, Wang X, Wu X, Castellani L . Chylomicronemia elicits atherosclerosis in mice--brief report. Arterioscler Thromb Vasc Biol. 2009; 30(1):20-3. PMC: 2796285. DOI: 10.1161/ATVBAHA.109.196329. View

10.

Milne R, Marcel Y, Retegui L . Characterization of monoclonal antibodies against human apolipoprotein E. J Clin Invest. 1981; 68(1):111-7. PMC: 370778. DOI: 10.1172/jci110225. View

11.

Zelcer N, Hong C, Boyadjian R, Tontonoz P . LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science. 2009; 325(5936):100-4. PMC: 2777523. DOI: 10.1126/science.1168974. View

12.

Beigneux A, Franssen R, Bensadoun A, Gin P, Melford K, Peter J . Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler Thromb Vasc Biol. 2009; 29(6):956-62. PMC: 2811263. DOI: 10.1161/ATVBAHA.109.186577. View

13.

Olivecrona G, Ehrenborg E, Semb H, Makoveichuk E, Lindberg A, Hayden M . Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. J Lipid Res. 2009; 51(6):1535-45. PMC: 3035517. DOI: 10.1194/jlr.M002717. View

14.

Franssen R, Young S, Peelman F, Hertecant J, Sierts J, Schimmel A . Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Circ Cardiovasc Genet. 2010; 3(2):169-78. PMC: 2858258. DOI: 10.1161/CIRCGENETICS.109.908905. View

15.

Badellino K, Wolfe M, Reilly M, Rader D . Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med. 2005; 3(2):e22. PMC: 1316064. DOI: 10.1371/journal.pmed.0030022. View

16.

Dong J, Weisgraber K, Segelke B, Rupp B, Capila I, Hernaiz M . Interaction of the N-terminal domain of apolipoprotein E4 with heparin. Biochemistry. 2001; 40(9):2826-34. DOI: 10.1021/bi002417n. View

17.

Chang S, Reich B, Brunzell J, Will H . Detailed characterization of the binding site of the lipoprotein lipase-specific monoclonal antibody 5D2. J Lipid Res. 1998; 39(12):2350-9. View

18.

Zhang L, Lookene A, Wu G, Olivecrona G . Calcium triggers folding of lipoprotein lipase into active dimers. J Biol Chem. 2005; 280(52):42580-91. DOI: 10.1074/jbc.M507252200. View

19.

Davies B, Beigneux A, Barnes 2nd R, Tu Y, Gin P, Weinstein M . GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab. 2010; 12(1):42-52. PMC: 2913606. DOI: 10.1016/j.cmet.2010.04.016. View

20.

Weisgraber K, Rall Jr S, Mahley R, Milne R, Marcel Y, Sparrow J . Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J Biol Chem. 1986; 261(5):2068-76. View